Monday, June 5, 2023
WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.
Emeritus Professor of Medicine, University of Birmingham, Consultant Physician and Diabetologist, Heart of England NHS Foundation Trust, Birmingham, United Kingdom
Vice Chairman, Primary Care Diabetes, Europe Director, Sant Marti Primary Health Care Centres, Barcelona, Spain
Professor of Primary Care Diabetes and Vascular Medicine, Co-Director, Leicester Diabetes Centre, University of Leicester, United Kingdom
Head, Clinical Research, Division of Diabetology, Medical Department, St. Josef-Hospital, Bochum, Germany
This educational activity is intended for an international audience of non-US healthcare professionals, specifically general diabetologists, endocrinologists, and general practitioners involved in the treatment of patients with type 2 diabetes mellitus (T2DM).
The goal of this activity is to educate physicians on the implementation of European guidelines for T2DM. Guidelines stress achieving glycemic goals for more patients by emphasizing a treatment approach that targets each individual patient's needs and preferences.
Upon completion of this activity, participants will be able to:
WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.
Emeritus Professor of Medicine, University of Birmingham, Consultant Physician and Diabetologist, Heart of England NHS Foundation Trust, Birmingham, United Kingdom
Vice Chairman, Primary Care Diabetes, Europe Director, Sant Marti Primary Health Care Centres, Barcelona, Spain
Professor of Primary Care Diabetes and Vascular Medicine, Co-Director, Leicester Diabetes Centre, University of Leicester, United Kingdom
Head, Clinical Research, Division of Diabetology, Medical Department, St. Josef-Hospital, Bochum, Germany
The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CPD Released: 10/30/2015
Valid for credit through: 10/30/2016
processing....
